At a Glance
| 2-Fluorodeschloroketamine | 3-MeO-PCP | |
|---|---|---|
| Class | Dissociatives | Dissociatives |
| Common Dose (insufflated) | 45–100 mg | 5–10 mg |
| Total Duration | 0.6–1.4 hrs | 2.3–4 hrs |
| Routes | insufflatedoral |
2-Fluorodeschloroketamine, a Dissociatives, and 3-MeO-PCP, a Dissociatives, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Dissociativess, meaning they share a common pharmacological foundation. They share 39 documented effects in common, with 8 effects unique to 2-Fluorodeschloroketamine and 28 unique to 3-MeO-PCP. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 2-Fluorodeschloroketamine | 3-MeO-PCP | |
|---|---|---|
| Class | Dissociatives | Dissociatives |
| Common Dose (insufflated) | 45–100 mg | 5–10 mg |
| Total Duration | 0.6–1.4 hrs | 2.3–4 hrs |
| Routes | insufflatedoral |
| Effects | 47 documented | 67 documented |
| Interaction | Caution | |
| Level | 2-Fluorodeschloroketamine | 3-MeO-PCP |
|---|---|---|
| Threshold | 5 mg | 1 mg |
| Light | 10–45 mg | 2–5 mg |
| Common | 45–100 mg | 5–10 mg |
| Strong | 100–175 mg | 10–15 mg |
| Heavy | 175 mg | — mg |
| Level | 2-Fluorodeschloroketamine | 3-MeO-PCP |
|---|---|---|
| Threshold | 5 mg | 2 mg |
| Light | 10–25 mg | 4–8 mg |
| Common | 25–70 mg | 8–15 mg |
| Strong | 70–140 mg | 15–25 mg |
| Heavy | 140 mg | 25 mg |
| Level | Dose |
|---|---|
| Threshold | 2 mg |
| Light | 5–10 mg |
| Common | 10–20 mg |
| Strong | 20–25 mg |
| Heavy | 25 mg |
2-Fluorodeschloroketamine
3-MeO-PCP
2-Fluorodeschloroketamine
Compounding dissociative effects can cause confusion, mania, and loss of motor control
3-MeO-PCP